Do pharmacogenomic tests provide value to policy makers?
Pharmacoeconomics
.
2006;24(12):1173-7.
doi: 10.2165/00019053-200624120-00002.
Authors
Ya-Chen Tina Shih
,
Lajos Pusztai
PMID:
17129072
DOI:
10.2165/00019053-200624120-00002
No abstract available
Publication types
Editorial
MeSH terms
Cost-Benefit Analysis
Costs and Cost Analysis
Humans
Pharmacogenetics / economics*
Pharmacogenetics / legislation & jurisprudence*
Quality-Adjusted Life Years